After a competitive multi-state process, Accelr8 Technology Corporation has announced it will move its headquarters from Denver, CO to Tucson, AZ. Accelr8 Technology Corporation develops materials and instrumentation for advanced applications in medical instrumentation, basic research, drug discovery, and bio-detection.
With the move to Tucson, Accelr8 expects to bring highly skilled, high-wage jobs to Southern Arizona with plans to fill 65 positions over the next three years and the potential to grow to 200-300 employees in subsequent years. The company will occupy approximately 15,000 square feet of space after a build out of wet lab space. The company is expected to be operational by early 2013.
“Accelr8 is developing a revolutionary product in the diagnostics area, and we were impressed with the region’s emerging bioscience strength, innovation, and support that can help ensure our future success,” said Lawrence Mehren, president and CEO, Accelr8 Technology Corporation.
“Our region has the technical talent and workforce that Accelr8 needs,” said Jonathan Rothschild, mayor, City of Tucson. “We are quickly becoming recognized for our ‘innovation know how.'”
“This win shows that Tucson is poised to take off as a region that is attractive to bioscience companies,” said Stephen G. Eggen, TREO Chairman of the Board and CFO, Raytheon Missile Systems. “Locally, many partners worked very hard to win this deal in a unified fashion.”
